OROksana Romanova

Oksana Romanova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Oksana Romanova has a total of 57 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • MULTILEVEL MODEL OF EPIDEMIOLOGICAL SAFETY OF ENDOSCOPIC PROCEDURES

    by N. D. Kolomiets, M. G. Aliakseyeva, O. N. Romanova, O. N. Hanenko, Y. N. Yushko, O. V. Tonko, P. P. Sidorovich

    Background. Traditional control of endoscopic procedures based on recording individual nonconformities does not reflect the mechanisms of epidemiological risk formation and limits the prioritization of management decisions. Objective. To substantiate both a multilevel model of epidemiological safety of endoscopic procedures and its application in a risk-based epidemiological audit. Material and Methods. A methodological study of the epidemiological safety system was conducted using an audit checklist. A structural analysis of control criteria was performed with their grouping into functional blocks and identification of critical control points based on their association with infection transmission risk and the possibility of compensating for deviations at subsequent stages. International guidelines and current regulatory documents were used. Results. A multilevel model was developed, including the levels of initial readiness, endoscope reprocessing, fluid systems, as well as control and traceability. A distinction between control points and critical control points was substantiated: critical control points are localized at stages of the technological process and determine the possibility of infection transmission, whereas control points reflect system stability. It has been shown that epidemiological risk arises from a combination of violations at different system levels. Conclusion. The proposed model enables a shift from recording nonconformities to analyzing the mechanisms of epidemiological risk formation and allows prioritization of management decisions with a focus on critical control points.

  • SEROLOGICAL STRUCTURE OF IMMUNE STATUS TO HEPATITIS B VIRUS UNDER LONG-TERM VACCINATION

    by V. S. Vysotskaya, N. D. Kolomiets, I. N. Glinskaya, O. N. Romanova, E. V. Gapeenko

    Background. A significant proportion of hepatitis B virus-related chronic liver diseases and their adverse outcomes remain a major global health challenge. Under implementation of long-term routine vaccination programs, population immune status assessment is crucial for epidemiological surveillance. Objective. To assess the structure of population immune status to hepatitis B virus (HBV) based on combinations of anti-HBs and anti-HBc markers under implementation of long-term vaccination programs. Material and methods. A cross-sectional seroepidemiological study with a retrospective analysis of HBV immune status was conducted among the population of the Republic of Belarus. Serological markers were determined using an enzyme-linked immunosorbent assay (ELISA) for detection of HBsAg, antibodies to the viral surface antigen (anti-HBs), and total antibodies to the HB-core antigen (anti-HBc). The primary endpoints were the presence of anti-HBs and anti-HBc, while the secondary endpoints were their combination and association with age and vaccination status. A serum anti-HBs concentration of 10 mIU/mL or higher was considered seroprotective. Results. In the total cohort of 1,548 individuals examined, protective anti-HBs levels were detected in 54.26% (95% CI 51.77–56.73), reflecting the proportion of individuals in the population with signs of established immunity. Additionally, the proportion of individuals with signs of exposure to the virus (anti-HBc+, including those combined with anti-HBs) accounted to 15.65% (95% CI 13.77–17.63), significantly exceeding the proportion of post-infection immunity and reflecting the presence of a group of individuals with isolated anti-HBc. This indicates a significant contribution of natural circulation of the virus to the immunity formation. Conclusion. Serological heterogeneity of population immunity has been established in the population of the Republic of Belarus across different age groups, administrative territories, and vaccination statuses. The population immune structure regarding HBV includes post-vaccination and post-infection components, as well as a group of individuals with uncertain immune status, which should be considered in hepatitis B surveillance.

  • SPECTRUM OF ENTEROPATHOGENS IN CHILDREN WITH INFLAMMATORY BOWEL DISEASES

    by L. I. Kastsiukevich, O. N. Romanova, N. D. Kolomiets, E. O. Samoilovich, G. V. Semeiko

    Background. Alterations in intestinal microbiota composition are considered one of the key triggers of inflammatory bowel disease (IBD). Studying the spectrum of enteropathogens in children with IBD helps clarify the role of an infectious factor in the disease manifestation and progression. Objective. To characterize the spectrum of enteropathogens and their associations with clinical forms of IBD in children using molecular genetic methods. Material and Methods. A total of 118 pediatric patients with IBD were examined: 36 with Crohn’s disease (CD), 54 with ulcerative colitis (UC), and 28 with indeterminate colitis (IC). Enteropathogens were identified using the TaqMan Array Card platform (Applied Biosystems, USA) covering 34 pathogens. Statistical analysis included the χ² test, Fisher’s exact test, and 95% confidence intervals. Results. Enteropathogens were detected in 56.8% (67/118) of patients with IBD. Bacteria were identified significantly more often (61.2%) than viruses and protozoa (6% each). The predominant bacterial agent was Clostridioides difficile (74.6%), found both as a single infection and within mixed infections (p<0.001). Mixed bacterial infections accounted for 24%, mainly in UC patients (p=0.01). Among viruses, rotavirus was the most frequent, while Blastocystis predominated among protozoa. Enteropathogens were significantly less common in IC patients (p<0.001). Conclusion. More than half of children with IBD harbored concomitant enteropathogens, confirming the significance of an infectious factor in disease modulation. The predominance of C. difficile and the high rate of mixed infections in ulcerative colitis emphasize the role of microbiota imbalance and support the necessity of routine molecular screening in the diagnostic algorithm for pediatric IBD. The findings highlight the need for further investigation of infectioninflammation interactions to improve prevention and therapeutic strategies.

  • APPLICATION OF RISK ANALYSIS METHODOLOGY IN EPIDEMIOLOGICAL SURVEILLANCE IN ENDOSCOPY (REPORT 2)

    by N. D. Kolomiets, M. G. Alekseeva, O. N. Khanenko, O. V. Tonko, O. N. Romanova, Ya. N. Yushko

    Background. Diagnostic and therapeutic endoscopy has become a cornerstone of clinical practice due to its high diagnostic value. However, the growing use of endoscopy has been accompanied by an increasing number of adverse events, healthcare-associated infections holding a special place among them. Objective. To assess compliance with sanitary and epidemiological requirements during endoscope reprocessing in healthcare facilities of the Republic of Belarus and to identify infection control strategies in terms of risk-based audit. Material and Methods. The main methodological framework was based on risk assessment and prioritization approaches developed by the World Health Organization (WHO), the U.S. Centers for Disease Control and Prevention (CDC), and the European Society of Gastrointestinal Endoscopy (ESGE). Results. Analysis of 11 endoscopic units showed that overall technological discipline was generally maintained; however, some typical organizational and control deficiencies were identified. The highest number of nonconformities was recorded during leak testing: most facilities lacked leak testers and clear documentation procedures for test results. At the stage of final cleaning, violations included inappropriate brush selection and the state of brushes, unsuitable wiping materials, and expired reuse life of disinfectants. During high-level disinfection (HLD), there were noted inadequate exposure time, wrong minimum effective concentration of disinfectants or wrong temperature. At the same time, final operations – rinsing, drying and storage – were performed consistently, maintaining strict adherence to protocols. Conclusion. A comprehensive assessment demonstrated that the main risk factors were insufficient standardization of procedures and inadequate internal quality control, rather than direct violations of technological regulations. The introduction of checklists helped to structure both sanitary-epidemiological audit and monitoring procedures, to improve the accuracy of assessment, to ensure uniformity of requirements and to implement targeted corrective actions. The application of a risk-based approach in auditing endoscope reprocessing enhances the epidemiological safety of endoscopic procedures and supports the development of a sustainable internal infection risk surveillance system.

  • PECULIARITIES OF PARENTERAL VIRAL HEPATITIS EPIDEMIOLOGICAL SITUATION IN THE REPUBLIC OF BELARUS

    by V. S. Vysotskaya, N. D. Kolomiets, I. N. Glinskaya, O. N. Romanova, E. L. Gasich

    Background. Parenteral viral hepatitis remains a significant global health problem due to a heavy burden of the infection. According to the World Health Organization (WHO), as of 2022, an estimated 304 million people are living with chronic hepatitis B and C, hepatitis causing 1.3 million deaths annually. Objective. To determine the epidemiological characteristics of viral hepatitis B and C in the Republic of Belarus. Material and methods. The incidence of hepatitis B in the population of the Republic of Belarus was assessed using data from state and departmental statistical reporting forms as well as using epidemiological diagnostic methods: retrospective epidemiological analysis, descriptive and evaluative methods, and statistical methods. Results. The long-term dynamics of the incidence over the period of 1996-2024 is characterized by a moderate downward trend in the overall incidence rate of all nosological forms of PVH, with a rate of Tdec = -3.89% per year (p≤0.05). Hepatitis C predominates in the nosological structure of parenteral viral hepatitis, accounting for 78.00% of cases in the overall structure of all forms of parenteral viral hepatitis over the past 5 years. Since 2022, chronic hepatitis C has accounted for more than 70% of cases in the overall structure of all forms of parenteral viral hepatitis. Over the past 5 years, sexual transmission of both hepatitis B and hepatitis C has become dominant, accounting for more than 50% of the transmission routes. Moreover, this route of transmission is the most significant for the 30-59-year-old age cohort. More than 97% of parenteral viral hepatitis cases occur in individuals over 15 years of age, more than 50% being individuals aged 30-59 years, and since 2018, this proportion has exceeded 70% (73.09%; 95% CI: 72.57–73.62), p<0.05. The dynamics of the parenteral viral hepatitis epidemic process, with an overall rate of decline of -19.57% per year (p≤0.05), has been influenced by routine vaccination of newborns since 2000, the implementation of sanitary, antiepidemic, and non-specific preventive measures, and changes in the structure of morbidity. Conclusion. In the long-term dynamics of incidence over the period of 1996-2024, a moderate downward trend in the overall incidence rate of all nosological forms of parenteral viral hepatitis has been observed, with a rate of Tdec = -3.89% per year (p≤0.05). The identified epidemiological characteristics of PVH urge the epidemiological monitoring to refocus on adult risk groups while maintaining mandatory screening coverage for adolescents to ensure the timely detection of chronic and latent forms of infection.

  • Open Access

    SOME OF STUDY RESULTS FOR HEPATITIS B VACCINATION EFFECTIVENESS IN THE REPUBLIC OF BELARUS

    by V. S. Vysotskaya, N. D. Kolomiets, I. N. Glinskaya, O. N. Romanova

    Background. Viral hepatitis, including that caused by hepatitis B virus (HBV), is a significant public health problem of the current decade, and the world is still far from achieving its elimination by 2030. Objective. To investigate the prevalence of HBV markers and evaluate the effectiveness of vaccination in certain population groups. Material and methods. HBsAg, antibodies to surface antigen (anti-HBs) allowing to assess the protective immune response to HBV, and total antibodies to HB-core antigen of HBV (anti-HBc) as an indirect marker of the patient's contact with HBV were tested. The seroprotective concentration of specific antibodies in serum was considered to be 10 mIU/mL and higher (ELISA, test systems produced by Vector-Best JSC (Russian Federation). Prophylactic hepatitis B vaccination coverage (documented vaccination) was assessed by collecting and analyzing data on the availability of a full course of vaccination at primary health care level according to the data from primary medical documentation forms No. 063/u “Card of prophylactic vaccinations”, No. 064/u “Journal of prophylactic vaccination records”, and electronic databases of prophylactic vaccination records. Results. A full course of HBV vaccination ensures the formation of protective immunity in 68.35% of the examined individuals. The proportion of seropositive individuals decreases with the passing of time after completion of vaccination. The results of the study demonstrate the presence of 34.68% of seronegative subjects 15 or more years after the last dose of HBV vaccine. A survey of 1365 individuals identified 213 individuals – 15.65% (95% CI 13.77-17.63) – having anti-HBc. Conclusion. In order to achieve the targets of the Global Health Sector Strategy for elimination of viral hepatitis by 2030, it is necessary to focus both on vaccination organizational aspects within the framework of the National Immunization Schedule and on the implementing serological testing for at-risk populations with subsequent optimization of vaccination strategies.


  • Open Access

    APPLICATION OF RISK ANALYSIS METHODOLOGY IN EPIDEMIOLOGICAL AUDITS IN ENDOSCOPY (Report 1)

    by Н. Д. Коломиец, М. Г. Алексеева, О. Н. Романова, L. I. Kastsiukevich, О. Н. Ханенко, О. В. Тонко, Е. В. Гапеенко, Belarus The State Institution Republican Clinical Medical Center Of The Administration Of The President Of The Republic Of Belarus; Minsk District

    Background. Since endoscopy introduction in the last century the number and significance of endoscopic procedures have substantially increased globally. Concurrently, there has grown the risk of healthcare-associated infections (HAIs) during endoscopic procedures particularly due to equipment failures, breaches in endoscope reprocessing, and noncompliance with established guidelines. Objective. To develop a standardized checklist for epidemiological audits in endoscopy departments/units, based on the risk analysis methodology. Material and methods. The study employed a risk assessment and prioritization framework (WHO, 2021) as its core methodology. Results. A qualitative four-level risk grading scale, marked using a “traffic light” system, was designed and integrated into the checklist. The checklist covered two audit domains: (1) “General Training of Medical Staff” (13 items) and (2) “Assessment of Infrastructure, Equipment, and Technological Processes in Endoscopy Units” (23 items). The developed tool was piloted in nine endoscopy departments across healthcare facilities in the Republic of Belarus. In the first domain, 58 total non-conformities were identified: 47 (81%) classified as Categories A and B, 10 (17%) as Category C, and 1 as Category D. In the second domain, 87 non-conformities were documented: 62 (71%) in Categories A and B, 12 (14%) in Category C, and 13 (15%) in Category D. These findings suggest that a significant proportion of non-conformities remain undetected in routine practice, potentially leading to serious complications and systemic failures over time. Conclusion. The integration of a systematic risk assessment approach through the use of standardized checklists and Standard Operating Procedures (SOPs) creates a synergistic effect that enhances risk management processes. This strategy contributes to improved safety and quality in endoscopy-related healthcare delivery.


  • CONGENITAL DEFECTS OF THE IMMUNE SYSTEM AS A MANIFESTATION OF MONOGENIC INFLAMMATORY BOWEL DISEASE IN CHILDREN

    by L. I. Kastsiukevich, O. N. Romanova, A. P. Mikhalenko, N. D. Kolomiets, K. Y. Marakhovsky, А. A. Gusina, Minsk Republican Scientific And Practical Center Mother And Child, O. N. Nazarenko, R. N. Mankevich, Ye. M. Marochkina, et al.

    Background. Currently, monogenic inflammatory bowel disease-like (IBD) pathologies such as congenital immunity defects, genetic epithelial barrier defects and others are becoming increasingly relevant. Objective. To analyze genetic defects associated with IBD-like immunopathology. Material and methods. The study included 46 patients with IBD manifestations aged 18 years or younger, who underwent whole-exome sequencing using the NGS method. All calculations were performed using the R statistical package, version 4.1. Results. There were identified 11 (23,9%) patients with gene mutations indicating congenital defects of the immune system (CDIS). Of these, 3 (27,3%) children were found to have abnormalities in the genes of immune dysregulation - CTLA-4 (c.151C>T (p.Arg 51*)), (FOXP3 (c.851C>T (p.Ala284Val)) and FOXP3 (c.748_750del (p.Lys250del)); 3 (27.3%) patients had abnormalities in the SLC5A1 gene (c.1666-2delA), SLC5A1 gene (c.1666-2delA and c.1680T>G(p.(Cys560Trp)) responsible for the disruption of the barrier function of the epithelium; 2 (18.2%) patients had abnormalities in the PIK3CD gene (c.3061G>A (p.Glu1021Lys)), manifested as CDIS with a predominant deficiency of antibodies; in 2 (18.2%) patients abnormalities in genes affecting cellular and humoral immunity were detected: JAK3 (c.2518C>T(p.Arg840Cys)), CD40LG (c.430G>A (p.Gly144Arg)); and in one case (9,1%) a congenital defect in the number or function of phagocytes – in CFTR gene (c.43delC (p.Leu15fs) and c.1210-11T>G) was established. According to clinical signs, patients with CDIS had only some differences from IBD patients. Conclusion. It is advisable to conduct molecular genetic analysis of target genes in IBD patients with very early onset of gastrointestinal lesions, which allows timely diagnosis of congenital defects of the immune system for subsequent prescription of adequate therapy.

  • Antibody-based biological antiviral drugs for the prevention and treatment of acute respiratory viral infections in immunocompromised patients: focus on safety

    by Natalya Geppe, Andrey Zaplatnikov, Elena Kondyurina, Boris Blokhin, Vera Revyakina, Sagira Abdrakhmanova, Oksana Romanova, Natalia Kolosova

    The safety of drug therapy is of particular importance for immunocompromised patients. This aspect acquires high importance in the context of choosing tactics for the prevention and treatment of acute respiratory viral infections. The review presents data on the features of the antiviral immune response and common cold/influenza in patients with a burdened allergic history and a brief overview of the results of clinical studies on the effectiveness and safety of innovative biological antiviral drugs based on antibodies to biological targets – Ergoferon, Anaferon for children and Anaferon. The drugs have a targeted effect on the immune system in accordance with their pharmacological targets, have a significant evidence base, including a meta-analysis of clinical trials for each drug according to the indication "acute respiratory viral infections/influenza", as well as individual studies, including double-blind placebo-controlled randomized, with this pathology in immunocompromised patients. The article also includes the results of a generalized safety analysis of the use of the above drugs for the prevention and treatment of acute respiratory viral infections/influenza in patients with concomitant allergic and autoimmune pathology. The results of the conducted studies, meta-analyses and generalized statistical analysis of data on the use of the drugs Anaferon for children, Anaferon, Ergoferon for the prevention and treatment of acute respiratory viral infections/ influenza indicate proven efficacy and a favorable safety profile and allow us to recommend drugs for wide use with preventive and therapeutic purposes in accordance with indications, including patients with allergic and autoimmune pathology.

  • Open Access

    THE ECONOMIC BURDEN OF INVASIVE FORMS OF MENINGOCOCCAL INFECTION

    by E.N. Sergienko, I.N. Kozhanova, O.N. Romanova, A.D. Solodov, P.A. Scutova

    Relevance Invasive meningococcal infection (IMI) is a significant clinical problem and is associated with a high probability of severe complications and death. Vaccination programs against meningococcus can achieve significant clinical effectiveness and require significant financial costs. This makes it relevant to study the economic burden of meningococcal infection in the conditions of modern healthcare in order to obtain basic data for subsequent research in the field of evaluation of medical technologies. Aims To assess the economic burden of IMI in children in the conditions of healthcare in the Republic of Belarus. Material and methods a retrospective study using the “cost of illness” method was conducted for 22 children hospitalized in the city children’s infectious clinical diseases hospital in 2018-2019. All values are presented in belarusian rubles. The average ± standard deviation, minimum – maximum values, median [Q1, Q3], cost shares (%) are calculated for the cost values. The minimum– maximum values and median [Q1, Q3] were calculated for the age of the patients. Results taking into account the costs of treatment in healthcare organizations of all patients studied, the share of direct costs of hospitalization was 29.0%, the share of direct costs of diagnosis - 7.2%, the share of direct costs of pharmacotherapy - 8.3%. A significant part of the costs accounted for observations after discharge and amounted to 55.4%. Conclusion a retrospective study of the economic burden of MI in the Republic of Belarus using the “cost of illness” method in patients hospitalized in a public health organization demonstrates a significant economic burden of this disease, which in the long term is primarily due to the presence of complications in the patient, as well as the impact of the patient’s death on the value of total costs.